ÂÜÀòÂÒÂ×

AJ Silver is an experienced finance professional currently serving as the Vice President of Corporate Finance at CRISPR Therapeutics. Previous roles include Executive Director of Finance & Accounting and Senior Director of Reporting & Technical Accounting at the same company. AJ Silver also has a background in assurance services as a Senior Manager at E&Y and began a career as a Financial Analyst at Summit Partners. Additionally, AJ Silver started in the field as a Public Accountant at Ernst & Young.